One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Isotretinoin and Adverse Psychiatric Effects
Parker Magin, PhD1; Shaun Prentice, PhD2
doi : 10.1001/jamadermatol.2023.4577
January 2024, Vol 160, No. 1, Pages 15-118
Cardiovascular and Venous Thromboembolic Risk With JAK Inhibitors in Immune-Mediated Inflammatory Skin Diseases
Jenne P. Ingrassia, BA1,2; Muhammad Haisum Maqsood, MD3; Joel M. Gelfand, MD4; Brittany N. Weber, MD, PhD5; Sripal Bangalore, MD1; Kristen I. Lo Sicco, MD1; Michael S. Garshick, MD1,6
Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms
Marie-Charlotte Brüggen, MD, PhD1,2,3,4; Sarah Walsh, MB, BCh, BMedSci4,5; M. Milad Ameri, MS1,2,3; Natalie Anasiewicz, MD1; Emanual Maverakis, MD6; Lars E. French, MD, PhD4,7,8; Saskia Ingen-Housz-Oro, MD4,9,10,11; and the DRESS Delphi consensus group
Perceptions of US-Based Muslim Patients of Their Dermatology Care
Ghida El-Banna, MD, MPP1; Shawheen Justin Rezaei, MPhil1; Michelle Chang, BA1; Sylvia Bereknyei Merrell, PhD1; Elizabeth E. Bailey, MD1; Nour Kibbi, MD1
Risk of Suicide and Psychiatric Disorders Among Isotretinoin Users
Nicole Kye Wen Tan1; Adelina Tang1; Neil Chen Yi Lun MacAlevey1; Benjamin Kye Jyn Tan, MBBS(Hons)1; Hazel H. Oon, MD2
Efficacy and Safety of the Heat Shock Protein 90 Inhibitor RGRN-305 in Hidradenitis Suppurativa
Hakim Ben Abdallah, MD1; Anne Bregnhøj, MD1; Thomas Emmanuel, MD1; Gautam Ghatnekar, PhD2; Claus Johansen, DMSc1; Lars Iversen, MD, DMSc1
Risk of Paradoxical Eczema in Patients Receiving Biologics for Psoriasis
Ali Al-Janabi, MA (Cantab)1,2; Oras A. Alabas, PhD3; Zenas Z. N. Yiu, PhD1,2; Amy C. Foulkes, PhD1,2; Steve Eyre, PhD1,4; Adnan R. Khan, PhD5; Nick J. Reynolds, MD6; Catherine H. Smith, PhD7,8; Christopher E. M. Griffiths, MD1,2; Richard B. Warren, PhD1,2; for the BADBIR Study Group
Oral Acitretin Plus Topical Triamcinolone vs Topical Triamcinolone Monotherapy in Patients With Symptomatic Oral Lichen Planus
Keshavamurthy Vinay, MD, DNB1; Sheetanshu Kumar, MD1; Anubha Dev, MD, DNB1; Simone Cazzaniga, PhD2,3; Luca Borradori, MD2; Vishal Thakur, MD1; Sunil Dogra, MD, DNB1
Evaluation of DermSat-7 for Assessing Treatment Satisfaction in Patients with Acne
Ali Shields, BS1,2; April W. Armstrong, MD, MPH3; Manraj N. Kaur, PhD4; Alison Layton, MBChB5,6; Diane Thiboutot, MD7; Jerry Tan, MD8,9; John S. Barbieri, MD, MBA1,10
Evaluation of Stigma Toward Individuals With Acne
Ali Shields, BS1,2; Michael R. Nock, BA3; Sophia Ly, BA2,4; Priya Manjaly, BA2,5; Arash Mostaghimi, MD, MPH, MPA2,6; John S. Barbieri, MD, MBA2,6,7
The Best Psoriasis Medications Emerge
Andrew Blauvelt, MD, MBA1; Megan H. Noe, MD, MPH, MSCE2
Podoconiosis
Miguel Mansilla-Polo, MD1,2; Paula Teresa López-León, MD2,3; Rafael Botella-Estrada, MD, PhD1,2,4
Acrodermatitis Enteropathica
Aravind Sivakumar, MD, DNB1; Rashmi K. Vageshappa, MBBS1; Rashmi Kumari, MD1
Multiple Umbilicated Papules on the Face
Juan Bai, MD1; Jianjun Qiao, MD, PhD1
Fast-Growing Frontal Subcutaneous Nodule in a Young Woman
Cristina Barrabés-Torrella, MD1; Gemma Melé-Ninot, MD1; MarÃa Teresa Fernández-Figueras, PhD2
Rituximab and Omalizumab Combination Therapy for Bullous Pemphigoid
Stephanie T. Le, MD1; Samantha Herbert, MSPH1; Reneé Haughton, MD1; Jordan Nava, BS1; Atrin Toussi, MD1; Antonio Ji-Xu, MA, BM, BCh1; Emanual Maverakis, MD1
Keratinocyte Carcinoma Incidence by Race and Ethnicity in Older Adults With Medicare Coverage
Lucy J. Navsaria, MBBCh, BAO, MPH1; Yao Li, MS1; Sanjna Tripathy, BA2; Cassandra A. Mohr, BS2; Candice L. Hinkston, MPH1; David J. Margolis, MD, PhD3,4; Mackenzie R. Wehner, MD, MPhil1,5
Barber Knowledge and Recommendations for Pseudofolliculitis Barbae
Xavier Rice, MD1,2; Deega Omar, MD, MPH3; Brandon P. Goodwin, MD1; Prince Adotama, MD4
Successful Treatment of Eosinophilic Pustular Folliculitis With Dupilumab
Marie Ottavi, MD1; Marine Velin, MD1; Nathalie Cardot Leccia, MD3; Thierry Passeron, MD, PhD1,2
Concurrent Langerhans Cell Histiocytosis and Acute Myeloid Leukemia Without Clonal Relationship
Sebastian Beckmann, MD1; Mike Kliffen, MD, PhD2; Auke Huijben, MD1; Hendrikus Jan Dubbink, MD, PhD3; Yorick Sandberg, MD, PhD1
The Consideration of Cyclosporine in the Treatment of Stevens-Johnson Syndrome
Hamza Malick, BS1; Kyle Lauck, MD2; Dario Kivelevitch, MD2
The Consideration of Cyclosporine in the Treatment of Stevens-Johnson Syndrome—Reply
Yuki Miyamoto, MD, MPH1,2; Hiroyuki Ohbe, MD, DrPH2,3; Hideo Yasunaga, MD, PhD2
